BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Medisse, a Dutch Biomaterial Company, Raises €2,6 Million Funding for Its Lead Product FlexiSurge Adhesion Barrier


1/28/2013 2:13:09 PM

EDE, The Netherlands--(BUSINESS WIRE)--Medisse B.V., announced the closure of a Series B equity financing round for the clinical trial of its lead product FlexiSurge® Adhesion Barrier. New investor IIG joins the existing investors, BioGeneration Ventures and Omnes Capital in the round. In addition Medisse will receive an innovation credit from the Dutch Ministry of Economic Affairs. Medisse is active in resorbable implants for soft tissue applications, based on a patented flexible polymer platform.

Read at BioSpace.com

 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->